No Data
List of conversion stocks (Part 1) [Parabolic Signal Conversion Stocks]
○List of stocks undergoing Buy conversion in the market Code Stock Name Closing Price SAR Tokyo Main Board <1301> Kiyokyo 4115 3945 <1332> Nissui 900873 <1377> Sakata Seed 34703370 <1726> Br. HD 346330 <1802> Obayashi Corporation 21012025 <1808> Haseko Corporation 20491980 <1820> Nishimatsu Construction 52485066 <1887> Japan National.
DNA, ETC [Stocks with Interest Viewed from Changes in Volume]
Closing price compared to the previous day Volume *<1483> iShares 2,896,811,217 *<162A> AI Select Daily Stock ETN 1,032,520,051,26 *<7044> Piarra 250,192,639,100 *<1474> One ETF Nikkei 26,190,695,954,7 *<2323> fonfun 884,118,107,200 *<1369> DIAM 225,405,108,501,5507 *<1625> Electronics Precision 391,106,701,466 *<234A>
Volume change rate ranking (9 AM) ~ Publishing trade, leaf gas ETC are ranked.
In the volume change rate ranking, by comparing the average volume over the last five days with the volume on the distribution day, it is possible to understand the trends of interest among market participants. ■ Top Volume Change Rates [As of December 27, 9:32] (Comparison with average volume over the last five days) Stock Code Stock Name Volume 5-Day Average Volume Volume Change Rate Stock Price Change Rate <8072> Publishing Trade 50079.63 16.57% 0% <9539> Leaf Gas 604500351 63.46
Torii Pharmaceutical To Go Ex-Dividend On December 27th, 2024 With 60 JPY Dividend Per Share
December 26th (Japan Standard Time) - $Torii Pharmaceutical(4551.JP)$ is trading ex-dividend on December 27th, 2024.Shareholders of record on December 31st, 2024 will receive 60 JPY dividend per
Verrica Pharmaceuticals' Partner Torii Seeks Japan Approval for Skin Infection Treatment
Verrica Pharmaceuticals Announces That Development Partner Torii Pharmaceutical Files New Drug Application of TO-208 the Treatment of Molluscum Contagiosum in Japan